Cohort study evaluates post-acute complications and health-care utilization in nonhospitalized individuals with SARS-CoV-2, highlighting outpatient recovery outcomes.
Background Individuals admitted to hospital for COVID-19 might have persisting symptoms (so-called long COVID) and delayed complications after discharge. However, little is known regarding the risk for those not admitted to hospital. We therefore examined prescription drug and health-care use after SARS-CoV-2 infection not requiring hospital admission.
No takes yet. Share an insight, caveat, or question.
Lund et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: